Patents by Inventor Foye Opawale

Foye Opawale has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9186321
    Abstract: The present disclosure is directed to chemically-stable and pharmaceutically acceptable sildenafil oral spray formulations for the treatment of diseases such as pulmonary arterial hypertension and/or SSRI-induced sexual dysfunction, wherein the oral spray formulation has a pH of about 1.5 to less than 3.0. The present disclosure is also directed to methods for treating diseases such as pulmonary arterial hypertension and/or SSRI-induced sexual dysfunction.
    Type: Grant
    Filed: December 4, 2012
    Date of Patent: November 17, 2015
    Assignee: Suda Ltd.
    Inventors: David Bergstrom, Foye Opawale
  • Publication number: 20150051216
    Abstract: The present disclosure is directed to chemically-stable and pharmaceutically acceptable sildenafil oral spray formulations for the treatment of diseases such as pulmonary arterial hypertension and/or SSRI-induced sexual dysfunction, wherein the oral spray formulation has a pH of about 1.5 to less than 3.0. The present disclosure is also directed to methods for treating diseases such as pulmonary arterial hypertension and/or SSRI-induced sexual dysfunction.
    Type: Application
    Filed: December 4, 2012
    Publication date: February 19, 2015
    Applicant: SUDA LIMITED
    Inventors: David Bergstrom, Foye Opawale